Mechanism of action of antimycobacterial activity of the new benzoxazinorifamycin KRM-1648.
The mechanism of antimicrobial activity of KRM-1648 (KRM), a new rifamycin derivative with potent antimycobacterial activity, was studied. Both KRM and rifampin (RMP) inhibited RNA polymerases from Escherichia coli and Mycobacterium avium at low concentrations: the 50% inhibitory concentrations (IC5...
Bewaard in:
| Gepubliceerd in: | Antimicrob Agents Chemother |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society for Microbiology (ASM)
1995
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162768/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7492091/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.7.1489 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|
